Comparison of remission criteria in a tumour necrosis factor inhibitor treated rheumatoid arthritis longitudinal cohort: patient global health is a confounder

INTRODUCTION: Our objectives were to assess the frequency and sustainability of American College of Rheumatology (ACR)/European League against Rheumatism (EULAR) and Disease Activity Score (DAS)28(4v)–C-reactive protein (CRP) remission 12 months after the initiation of tumour necrosis factor inhibit...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Balogh, Emese, Madruga Dias, Joao, Orr, Carl, Mullan, Ronan, Harty, Len, FitzGerald, Oliver, Gallagher, Phil, Molloy, Miriam, O’Flynn, Eileen, Kelly, Alexia, Minnock, Patricia, O’Neill, Madeline, Moore, Louise, Murray, Mairead, Fearon, Ursula, Veale, Douglas J
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2013
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3978469/
https://ncbi.nlm.nih.gov/pubmed/24365061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar4421
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak